About
Alzinova is a clinical-stage biopharma company developing an active vaccine immunotherapy using proprietary AβCC Peptide™ technology to treat Alzheimer's disease by targeting toxic Aβ oligomers.
Explore Alzinova's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.